- Home
- CAL vs PGEN Comparison
CAL vs PGEN Comparison
Compare CAL & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAL
- PGEN
- Stock Information
- Founded
- CAL 1878
- PGEN 1998
- Country
- CAL United States
- PGEN United States
- Employees
- CAL N/A
- PGEN N/A
- Industry
- CAL Shoe Manufacturing
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- CAL Consumer Discretionary
- PGEN Health Care
- Exchange
- CAL Nasdaq
- PGEN Nasdaq
- Market Cap
- CAL 446.5M
- PGEN 493.0M
- IPO Year
- CAL N/A
- PGEN N/A
- Fundamental
- Price
- CAL $15.51
- PGEN $4.18
- Analyst Decision
- CAL Hold
- PGEN Buy
- Analyst Count
- CAL 1
- PGEN 5
- Target Price
- CAL $14.00
- PGEN $7.50
- AVG Volume (30 Days)
- CAL 547.5K
- PGEN 15.4M
- Earning Date
- CAL 09-04-2025
- PGEN 08-12-2025
- Dividend Yield
- CAL 1.80%
- PGEN N/A
- EPS Growth
- CAL N/A
- PGEN N/A
- EPS
- CAL 2.43
- PGEN N/A
- Revenue
- CAL $2,677,706,000.00
- PGEN $4,340,000.00
- Revenue This Year
- CAL N/A
- PGEN $256.94
- Revenue Next Year
- CAL $3.48
- PGEN $759.81
- P/E Ratio
- CAL $6.41
- PGEN N/A
- Revenue Growth
- CAL N/A
- PGEN N/A
- 52 Week Low
- CAL $12.09
- PGEN $0.65
- 52 Week High
- CAL $44.51
- PGEN $4.21
- Technical
- Relative Strength Index (RSI)
- CAL 61.70
- PGEN 88.14
- Support Level
- CAL $14.34
- PGEN $2.94
- Resistance Level
- CAL $15.17
- PGEN $3.34
- Average True Range (ATR)
- CAL 0.59
- PGEN 0.32
- MACD
- CAL 0.09
- PGEN 0.22
- Stochastic Oscillator
- CAL 83.74
- PGEN 99.00
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.